Cynata Therapeutics Limited

Press Releases

2016-November-29	Cynata Files Further Patent Application (in PDF)
2016-November-15	Cynata Receives $1.749m R&D Tax Incentive Refund (in PDF)
2016-October-17	Cynata's MSC Technology Demonstrates Significant Efficacy in Preclinical Asthma Study (in PDF)
2016-September-19	UK Regulatory Authority Approves Cynata GvHD Clinical Trial (in PDF)
2016-September-5	Cynata Determines Not to Proceed with Regience Investment Offer (in PDF)
2016-September-5	Cynata and FUJIFILM Sign Non-binding Development and Commercialisation Term Sheet (in PDF)
2016-August-1	Cynata Files Application to Commence Phase 1 Clinical Trial (in PDF)
2016-June-30	Cynata Receives Investment Offer from Regience (in PDF)
2016-June-21	Cynata Prepares for Phase 1 Clinical Trial (in PDF)
2016-June-9	Cynata Appoints Paul K Wotton Ph.D. to Board of Directors (in PDF)
2016-May-9	Cynata Enters License Option Agreement with apceth GmbH & Co. KG (in PDF)
2016-May-5	Cynata Commences Manufacture of Clinical Trial Product; Files Further Patent Application (in PDF)
2016-May-2	Cynata Announces Japanese Patent Office Decision to Grant Patent for Cymerus™ MSC technology (in PDF)
2016-April-29	Cynata & Regience Extend Entitlement Period (in PDF)
2016-April-7	Cynata Reports Compelling Results from Pre-clinical Stem Cell Study in Graft-versus-Host Disease (GvHD) (in PDF)
2016-March-3	Cynata Enters Agreement for Strategic Alliance in Japan (in PDF)
2016-February-16	Cynata Receives $930k R&D Tax Incentive Refund (in PDF)
2016-January-28	Cynata Receives Favourable Advice from UK Regulatory Authority (in PDF)
2016-January-12	Cynata CLI Study Published in Peer-Reviewed Journal (in PDF)
2015	2015 Press Releases
2014	2014 Press Releases
2013	2013 Press Releases